Difference between revisions of "Amniotic fluid embolism"
From WikiAnesthesia
(started) |
|||
| Line 10: | Line 10: | ||
}} | }} | ||
An amniotic fluid embolism is a rare but serious condition with high morbidity and mortality. | An amniotic fluid embolism (AFE) is a rare but serious condition with high morbidity and mortality. It is characterized by cardiopulmonary collapse and disseminated intravascular coagulation (DIC). It is the second-leading cause of peripartum maternal death in the US and number one cause of peripartum cardiac arrest. <ref>{{Citation|last=Haftel|first=Anthony|title=Amniotic Fluid Embolism|date=2022|url=http://www.ncbi.nlm.nih.gov/books/NBK559107/|work=StatPearls|place=Treasure Island (FL)|publisher=StatPearls Publishing|pmid=32644533|access-date=2022-10-20|last2=Chowdhury|first2=Yuvraj S.}}</ref> | ||
== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> == | == Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> == | ||
| Line 20: | Line 20: | ||
=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> === | === Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> === | ||
== | == Risk Factors<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. -->== | ||
Risk factors for the development of AFE are advanced maternal age, multiparity, male fetuses, and trauma. | |||
== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> == | == Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> == | ||
AFE is poorly understood. | |||
== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> == | == Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> == | ||
Revision as of 13:43, 20 October 2022
Amniotic fluid embolism
| Anesthetic relevance | |
|---|---|
| Anesthetic management |
{{{anesthetic_management}}} |
| Specialty | |
| Signs and symptoms | |
| Diagnosis | |
| Treatment | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
An amniotic fluid embolism (AFE) is a rare but serious condition with high morbidity and mortality. It is characterized by cardiopulmonary collapse and disseminated intravascular coagulation (DIC). It is the second-leading cause of peripartum maternal death in the US and number one cause of peripartum cardiac arrest. [1]
Anesthetic implications
Preoperative optimization
Intraoperative management
Postoperative management
Risk Factors
Risk factors for the development of AFE are advanced maternal age, multiparity, male fetuses, and trauma.
Pathophysiology
AFE is poorly understood.
Signs and symptoms
Diagnosis
Treatment
Medication
Surgery
Prognosis
Epidemiology
References
- ↑ Haftel, Anthony; Chowdhury, Yuvraj S. (2022), "Amniotic Fluid Embolism", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32644533, retrieved 2022-10-20